Positron Corporation Secures Three New Orders For Advanced 64-Slice PET-CT Systems

Positron Corporation, a company specializing in advanced molecular imaging technology and PET imaging solutions, has announced that it has received three new orders for its 64-slice PET-CT systems. Each order also includes a multi-year service agreement and comes from leading nuclear cardiologists whose practices focus on advanced cardiovascular diagnostics and interventional cardiac care. The new contracts represent another important step in the company's commercial growth as demand for advanced cardiac imaging continues to increase.

The latest orders strengthen Positron's market presence by combining new equipment sales with long-term service agreements that generate recurring revenue. The company believes the growing interest in its PET-CT systems reflects increasing confidence in its advanced imaging technology, comprehensive customer support, and cost-effective solutions. As more healthcare providers move from traditional Single Photon Emission Computed Tomography (SPECT) imaging to cardiac PET imaging, Positron expects to benefit from the expanding demand for more accurate and efficient diagnostic technologies.

Commenting on the announcement, Adel Abdullah, President and Chairman of Positron Corporation, said the company is entering an important phase that could reshape the molecular imaging industry. He noted that as Positron prepares for the commercial launch of its advanced PET-CT platform, it is seeing strong interest from hospitals and private medical practices across the United States, along with growing attention from international markets. He added that the company's combination of advanced imaging technology, comprehensive support services, and competitive economics has the potential to accelerate the adoption of PET imaging and encourage healthcare providers to transition from conventional SPECT systems.

Positron also expects the commercial launch of its latest PET-CT platform to attract a significant number of new cardiac imaging customers. The company believes this will help expand its installed base, strengthen customer relationships through long-term service agreements, and reinforce its position in the rapidly growing molecular imaging market. By offering both innovative technology and ongoing technical support, Positron aims to provide healthcare providers with a complete imaging solution that delivers long-term clinical and operational value.

The company's 64-slice PET-CT systems are designed to deliver high-quality imaging for both cardiac and oncology applications. The systems feature high-sensitivity detector technology, a patient-friendly 72-centimeter wide-bore gantry, and one of the smallest and lightest footprints in their class, making installation easier for healthcare facilities. They are also designed to improve workflow efficiency, reduce radiation exposure for patients, and integrate smoothly into a wide range of clinical environments.

With more than three decades of experience in molecular imaging and tens of thousands of clinical scans performed across the United States, Positron has established itself as a trusted provider of PET imaging solutions. The company combines advanced PET-CT technology with comprehensive clinical, technical, and operational support, helping healthcare providers confidently adopt advanced molecular imaging while improving diagnostic capabilities and patient care.